Hjem › Nyrekreft (nyrecellekarcinom) › Utah
Kliniske studier for Nyrekreft (nyrecellekarcinom) i Utah
7 studier for Nyrekreft (nyrecellekarcinom) søker deltakere på steder i Utah.
Byer i Utah
Offisiell studietekst (engelsk)
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- START Mountain Region, West Valley City
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06270706Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- University of Utah - Huntsman Cancer Institute, Salt Lake City
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT05267626ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Utah Cancer Specialists, Salt Lake City
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT05059444A Study of MGC026 in Participants With Advanced Solid Tumors
- START Mountain Region, West Valley City
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 11. aug. 2026 · NCT06242470Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
- START Mountain Region, West Valley City
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 10. jun. 2026 · NCT07517198Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 30. apr. 2026 · NCT05297734Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
- George E Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2025 · NCT04510597Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.